-+ 0.00%
-+ 0.00%
-+ 0.00%

PDS Biotechnology Q1 EPS $(0.13) Beats $(0.15) Estimate

Benzinga·05/13/2026 11:01:21
Listen to the news
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 38.1 percent increase over losses of $(0.21) per share from the same period last year.